Stereotaxis Inc
For the period ended Dec 31, 2023. Filed Mar 8, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 8, 2024
STXS$1.03-9.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Balance Sheets at December 31, 2023 and 2022
BALANCE SHEETS
| (in thousands, except share amounts) | December 31, 2023 | December 31, 2022 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $19,818 | $8,586 |
| Restricted cash - current | 525 | 525 |
| Short-term investments | - | 19,844 |
| Accounts receivable, net of allowance of $672 and $235 at 2023 and 2022, respectively | 3,822 | 5,090 |
| Inventories, net | 8,426 | 7,876 |
| Prepaid expenses and other current assets | 676 | 1,325 |
| Total current assets | 33,267 | 43,246 |
| Property and equipment, net | 3,304 | 3,831 |
| Restricted cash | 219 | 744 |
| Operating lease right-of-use assets | 4,982 | 5,384 |
| Prepaid and other non-current assets | 137 | 208 |
| Total assets | $41,909 | $53,413 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $3,190 | $3,270 |
| Accrued liabilities | 2,972 | 3,306 |
| Deferred revenue | 6,657 | 7,342 |
| Current portion of operating lease liabilities | 428 | 373 |
| Total current liabilities | 13,247 | 14,291 |
| Long-term deferred revenue | 1,637 | 1,654 |
| Operating lease liabilities | 5,062 | 5,488 |
| Other liabilities | 43 | 51 |
| Total liabilities | 19,989 | 21,484 |
| Series A - Convertible preferred stock: | ||
| Convertible preferred stock, Series A, par value $0.001; 22,358 and 22,383 shares outstanding at 2023 and 2022, respectively | 5,577 | 5,583 |
| Stockholders’ equity: | ||
| Convertible preferred stock, Series B, par value $0.001; 10,000,000 shares authorized, 5,610,121 shares outstanding at 2022 | - | 6 |
| Common stock, par value $0.001; 300,000,000 shares authorized, 80,949,697 and 74,874,459 shares issued at 2023 and 2022, respectively | 81 | 75 |
| Additional paid in capital | 554,148 | 543,438 |
| Treasury stock, 4,015 shares at 2023 and 2022 | (206) | (206) |
| Accumulated deficit | (537,680) | (516,967) |
| Total stockholders’ equity | 16,343 | 26,346 |
| Total liabilities and stockholders’ equity | $41,909 | $53,413 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.